Loading insider details...
Beta
Latest Form 4 (Sep 8, 2026): Grant/Award of 2,503,050 PYXS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 2,503,050 | n/a |
| Aug 14, 2026 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 250,956 | n/a |
| Feb 6, 2026 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 690,131 | n/a |
| Jan 29, 2026 | Repare Therapeutics Inc. (RPTX) | Disposition to Issuer | 7,500 | n/a |
| Apr 2, 2025 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 36,979 | $36.2K |
| Jun 20, 2024 | Repare Therapeutics Inc. (RPTX) | Grant/Award | 27,200 | n/a |
| Mar 28, 2024 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 44,024 | $168.6K |
| Jun 12, 2023 | Repare Therapeutics Inc. (RPTX) | Grant/Award | 27,200 | n/a |
| Mar 28, 2023 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 139,355 | n/a |
| May 16, 2022 | Repare Therapeutics Inc. (RPTX) | Grant/Award | 49,000 | n/a |